Zicronapine
- Generic Name
- Zicronapine
- Drug Type
- Small Molecule
- Chemical Formula
- C22H27ClN2
- CAS Number
- 170381-16-5
- Unique Ingredient Identifier
- QZV11V7G6A
- Background
Zicronapine has been used in trials studying the treatment of Schizophrenia.
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
Phase 2
Completed
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2011-06-21
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 46
- Registration Number
- NCT01377233
- Locations
- 🇺🇸
US001, Rockville, Maryland, United States
🇺🇸US004, San Diego, California, United States
🇺🇸US003, National City, California, United States
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 160
- Registration Number
- NCT01295372
- Locations
- 🇫🇷
FR004, Strasbourg, France
🇨🇿CZ001, Brno, Czech Republic
🇫🇷FR003, Toulon, France
Efficacy of Lu 31-130 in Patients With Schizophrenia
- First Posted Date
- 2008-10-10
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 93
- Registration Number
- NCT00770744
- Locations
- 🇨🇿
CZ004, Lnare, Czech Republic
🇨🇿CZ002, Olomouc, Czech Republic
🇫🇷FR002, Dole, France
Efficacy of Lu 31-130 in Patients With Schizophrenia
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2016-11-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 280
- Registration Number
- NCT00768326
- Locations
- 🇩🇪
DE001, Munich, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath